Variation in antibody titers determined by Abbott and Roche Elecsys SARS-CoV-2 assays in vaccinated healthcare workers

Authors: Nakai, Miku ^{a, 1}, Yokoyama, Daisuke ^{b, 1}, Sato, Tomoaki ^a, Sato, Ryohei ^b, Kojima, Chiari ^{b, ∗}, Shimosawa, Tatsuo ^{a, ∗∗}

Source: In Heliyon June 2023 9(6)

Association between sleep duration and antibody acquisition after mRNA vaccination against SARS-CoV-2

Authors: Muneto Izuhara, Kentaro Matsui, Takuya Yoshiike, Aoi Kawamura, Tomohiro Utsumi, Kentaro Nagao, Ayumi Tsuru, Rei Otsuki, Shingo Kitamura, Kenichi Kuriyama

Source: Frontiers in Immunology, Vol 14 (2023)

Subject Terms: mRNA SARS-CoV-2 vaccine, sleep and immunity, longer objective sleep duration, antibody titer, BNT-162b2, mRNA-1273, Immunologic diseases. Allergy, RC581-607

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fimmu.2023.1242302/full; https://doaj.org/toc/1664-3224

Access URL: https://doaj.org/article/0016e507f8a64fe981362c777632de9b

Characteristics and outcomes of adverse events after COVID‐19 vaccination

Authors: Kewan, Tariq ¹, Flores, Monica ¹, Mushtaq, Komal ¹, Alwakeel, Mahmoud ¹, Burton, Robert ², Campbell, James ³, Perry, Hunter ⁴, Al‐Jaghbeer, Mohammed ^{5, 6}, Abi Fadel, Francois ^{5, 6, *}

Source: In JACEP Open October 2021 2(5)

Analyses of reported severe adverse events after immunization with SARS-CoV-2 vaccines in the United States: One year on

Authors: Halinder S. Mangat, Anwar Musah, Susanne Luedtke, Akheel A. Syed, Boby V. Maramattom, Joel Maruthanal, Arnold Bosman, Patty Kostkova

Source: Frontiers in Public Health, Vol 10 (2022)

Subject Terms: COVID-19 vaccination adenovector, mRNA, severe adverse events following immunization, BNT-162b2 vaccine, mRNA-1273 vaccine, Ad26.COV2.S, Public aspects of medicine, RA1-1270

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fpubh.2022.972464/full; https://doaj.org/toc/2296-2565

Access URL: https://doaj.org/article/7085e659d4e84278b3fc90850a7fe150

Molecular Mimicry and HLA Polymorphisms May Drive Autoimmunity in Recipients of the BNT-162b2 mRNA Vaccine: A Computational Analysis

Authors: Rossella Talotta

Source: Microorganisms, Vol 11, Iss 7, p 1686 (2023)

Subject Terms: adaptive immunity, autoimmunity, BNT-162b2 vaccine, COVID-19, HLA, SARS-CoV-2, Biology (General), QH301-705.5

File Description: electronic resource

Relation: https://www.mdpi.com/2076-2607/11/7/1686; https://doaj.org/toc/2076-2607

Access URL: https://doaj.org/article/31a45551e6744df793d4f95bf34bd116

Prospective Cohort Study of the Kinetics of Specific Antibodies to SARS-CoV-2 Infection and to Four SARS-CoV-2 Vaccines Available in Serbia, and Vaccine Effectiveness: A 3-Month Interim Report

Authors: Olivera Lijeskić, Ivana Klun, Marija Stamenov Djaković, Nenad Gligorić, Tijana Štajner, Jelena Srbljanović, Olgica Djurković-Djaković

Source: Vaccines, Vol 9, Iss 9, p 1031 (2021)

Subject Terms: SARS-CoV-2, COVID-19, BNT-162b2, BBIBP-CorV, Gam-COVID-Vac, ChAdOx1-S, Medicine

File Description: electronic resource

Relation: https://www.mdpi.com/2076-393X/9/9/1031; https://doaj.org/toc/2076-393X

Access URL: https://doaj.org/article/b09027969142434c9e541eaa3f2c68bb

BNT162b2 COVID vaccine effective in children amid Delta, Omicron periods

Authors: By:Joshua Fitch, Senior Editor

Source: Contemporary Pediatrics (USA), January 17, 2024 News, 4pp

Despite mild to moderate adverse events, COVID-19 vaccination recommended in United States for children aged 5 to 11 years

Authors: By:Celeste Krewson

Source: Contemporary Pediatrics (USA), August 1, 2022 News, 2pp

Chest CT Study Shows Benefits of COVID-19 Vaccines in Reducing Incidence and Severity of Related Pneumonia

Authors: By:Jeff Hall

Source: Diagnostic Imaging (USA), June 2, 2022 News, 3pp

Pfizer Vaccine Reduces Risk of Long COVID in Pediatric Patients

Authors: By:Killian Meara

Source: Drug Topics (USA), December 20, 2024 News, 3pp

Third BNT162b2 COVID-19 Vaccine Dose Revives Humoral Response in MS Among Those Treated With Ocrelizumab, Fingolimod

Authors: By:Matt Hoffman

Source: Neurology Live (USA), October 28, 2022 News, 3pp

MS Treatment With Tolebrutinib Uninterrupted in Patients With COVID-19 Infection

Authors: By:Abby Reinhard

Source: Neurology Times (USA), March 1, 2022 News, 3pp

COVID-19 Antibodies Are Similar for Those With Solid Tumors Compared With Those Without 6-Months After the Second Dose

Authors: By:Ariana Pelosci

Source: CancerNetwork (USA), September 2, 2021 News, 3pp

FDA scientists say Pfizer vaccine is "highly effective" as outside panel meets Thursday

Authors: By:Hassan Abbas

Source: Arab American News, The (Dearborn, MI), December 8, 2020 Health, 3pp